Landiolol, sold by AOP Health under the brand name Rapiblyk, is an intravenous treatment designed to start working right away.

Hospitals and physicians are pressing lawmakers to pass two previously proposed pieces of legislation that allow international medical graduates to work here longer. 

FDA commissioner Robert Califf recently suggested the agency may need to double its workforce. And that’s just to oversee AI. 

The Centers for Medicare & Medicaid Services violated the Administrative Procedure Act by allowing a single phone call made by a contractor to determine a Medicare Advantage star rating, a federal judge ruled. 

The FDA’s fledgling Digital Health Advisory Committee (DHAC) only held its first meeting last week, but it has already committed its thinking to writing. 

41 members of the upper chamber recently penned a letter to colleagues, contending that inaction could impact seniors’ access to care. 

Embolization is a safe, cost-effective alternative to a hysterectomy, but patients are not using the IR service in some geographies. 

The Food and Drug Administration approval comes amid growing interest in remote-scan technology following the COVID pandemic.